Tinodasertib
目录号: PL07436 纯度: ≥99%
CAS No. :1464151-33-4
商品编号 规格 价格 会员价 是否有货 数量
PL07436-5mg 5mg ¥2349.09 请登录
PL07436-10mg 10mg ¥3585.45 请登录
PL07436-50mg 50mg ¥10261.82 请登录
PL07436-100mg 100mg ¥15454.55 请登录
PL07436-200mg 200mg 询价 询价
PL07436-500mg 500mg 询价 询价
PL07436-10mM*1mLinDMSO 10mM*1mLinDMSO ¥2584.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
Tinodasertib
英文名称
Tinodasertib
英文别名
ETC-206;Tinodasertib
Cas No.
1464151-33-4
分子式
C25H20N4O2
分子量
408.45
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
Tinodasertib (ETC-206) 是一种选择性 MNK1 和 MNK2 抑制剂,IC50 分别为 64 nM 和 86 nM。
生物活性
Tinodasertib (ETC-206) is a selective MNK1 and MNK2 inhibitor with IC 50 s of 64 nM and 86 nM, respectively.
性状
Solid
IC50 & Target[1][2]
MNK1 64 nM (IC50) MNK2 86 nM (IC50
体外研究(In Vitro)
Tinodasertib (ETC-206) inhibits eIF4E phosphorylation in HeLa cell line with an IC50 of 321 nM. The anti-proliferative effects of ETC-206 are assessed in vitro, using CellTiter-Glo viability assay against 25 hematological cancer cell lines including the K562 cell line that overexpresses eIF4E (K562 o/e eIF4E). The IC50s are 1.71 μM, 3.36 μM, 3.70 μM, 4.81 μM, 5.13 μM, 5.05 μM, 6.70 μM, 9.76 μM, and 48.8 μM for SU-DHL-6, GK-5, MC 116, P3HR-1, DOHH2, MPC-11, Ramos.2G6.4C10, AHH-1, and K562 o/e eIF4E cells, respectively. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
The antitumor effect of ETC-206 is then assessed in a K562 e/o eIF4E mouse xenograft model after oral administration at 25, 50, or 100 mg/kg alone or in combination with a 2.5 mg/kg fixed dose of Dasatinib throughout the study. Dasatinib at 2.5 mg/kg elicits a tumor growth inhibition (TGI) of 88% with one tumor-free animal. In contrast, ETC-206 alone only yields a maximum TGI of 23% at the highest administered dose of 100 mg/kg, which does not impede tumor growth, and is similar to the nontreated animals. ETC-206 with 2.5 mg/kg of Dasatinib not only increases tumor growth inhibition in a dose-dependent manner but, more importantly leads to 2, 5, and 8 out of 8 tumor-free animals at 25, 50, and 100 mg/kg, respectively. The combination of ETC-206 and Dasatinib inhibits tumor growth at all tested doses, and no weight loss is recorded. Both the combination of ETC-206 and Dasatinib
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Yang H, et al. Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia. J Med Chem. 2018 May 24;61(10):4348-4369.
溶解度数据
In Vitro: DMSO : ≥ 50 mg/mL (122.41 mM)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2